Zimmer Biomet Holdings, Inc. (ZBH) Fair Value 2026

ZBH · Orthopedic, Prosthetic & Surgical Appliances & Supplies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

3.7 /10

32 fundamental signals · 13 models active

Value Trap Risk

SAFE (12/100)

Quick Summary — As of 2026-07-15, Zimmer Biomet Holdings, Inc. (ZBH) trades at $90.14, approximately 418% above CirclFi’s Bayesian DCF fair value of $17.39. QOC: 3.7/10. Value Trap Risk: 12/100 (SAFE). 13/13 models active.

Key Facts

Ticker
ZBH
Price
$90.14
Quality Score
3.7/10
Value Trap Risk
12/100
Models Active
13/13
Last Updated
Strength: First Chicago suggests +23.9% upside with 49% confidence
Risk: Below-average Quality Score of 3.7/10 signals weak fundamentals

Is Zimmer Biomet Holdings, Inc. (ZBH) Undervalued or Overvalued in 2026?

According to CirclFi’s 13-model valuation engine, Zimmer Biomet Holdings, Inc. (ZBH) appears overvalued as of : the median of 13 independent fair value estimates is $31.12, 65.5% below the current price of $90.14. Estimates range from $1.56 to $135.38. ZBH scores 3.7/10 on fundamental quality and 12/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Zimmer Biomet Holdings, Inc. Stock in 2026? →

Valuation Matrix

13 Intrinsic Value Models vs. Current Price ($90.14)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
 $17.39 -80.7%
Earnings Power Value
High Conviction
 $31.12 -65.5%
CUCE Ensemble
Low Conviction
 $62.73 -30.4%
First Chicago
Medium Conviction
 $111.70 +23.9%

Unlock the Full Matrix

Access 9 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 13 Models →

Cancel anytime · No contracts · Instant access

What Is Zimmer Biomet Holdings, Inc. (ZBH) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Zimmer Biomet Holdings, Inc.'s intrinsic value is estimated at a composite fair value of $55.52. Trading at $90.14, the stock is approaching fair value or slight overvaluation (implied return of -38.4%), as 8 of 13 models suggest limited further upside. The most optimistic model, Regime Cross, places fair value at $135.38 (+50.2%), while RCMH-DCF — the most conservative — estimates $1.56 (-98.3%). This +148.5% gap reflects genuine analytical uncertainty about Zimmer Biomet Holdings, Inc.'s intrinsic worth.

What Do the Models Say About ZBH?

13 of 13 models are currently active for ZBH. Of these, 5 models suggest upside while 8 models suggest overvaluation. The Bayesian DCF estimates ZBH's intrinsic value at $17.39, implying -80.7% downside from the current price. See which stocks rank higher →

How Does ZBH Rank in Orthopedic, Prosthetic & Surgical Appliances & Supplies?

Among 25 Orthopedic, Prosthetic & Surgical Appliances & Supplies stocks, ZBH ranks #22 by Quality of Company score. CirclFi's QOC score of 3.7/10 evaluates 32 fundamental signals. A score of 3.7 signals below-average fundamentals.

Zimmer Biomet Holdings, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is ZBH a Value Trap?

CirclFi's Value Trap algorithm assigns ZBH a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

13 of 13 models are active for Zimmer Biomet Holdings, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Zimmer Biomet Holdings, Inc. earns a quality score of 3.7/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +148.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ZBH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ZBH's 13 active models, average confidence is 35%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Zimmer Biomet Holdings, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Orthopedic, Prosthetic & Surgical Appliances & Supplies Stocks Should You Also Analyze?

8 related Orthopedic, Prosthetic & Surgical Appliances & Supplies stocks with 13-model coverage

STESTERIS plc (Ireland)QOC 9.7ISRGIntuitive Surgical, Inc.QOC 9.5EWEdwards Lifesciences CorporatioQOC 8.9MSAMSA Safety IncorporatedQOC 8.8CDRECadre Holdings, Inc.QOC 8.3SNNSmith & Nephew SNATS, Inc.QOC 8.2SPAISafe Pro Group Inc.QOC 7.1ESTAEstablishment Labs Holdings IncQOC 7.1

Read investment analysis: STE · ISRG · EW · MSA · CDRE

Frequently Asked Questions About Zimmer Biomet Holdings, Inc.

What is Zimmer Biomet Holdings, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Zimmer Biomet Holdings, Inc. (ZBH) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $17.39. The Quality of Company score is 3.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ZBH overvalued or undervalued right now?

At $90.14, 5 of 13 active models suggest ZBH may be undervalued, while 8 indicate potential overvaluation. The median of all 13 fair value estimates is $31.12, 65.5% below the current price of $90.14 — a consensus view that ZBH is overvalued. The assessment depends on which methodology best fits Zimmer Biomet Holdings, Inc.'s business model in Orthopedic, Prosthetic & Surgical Appliances & Supplies.

What does a Quality of Company score of 3.7 mean for ZBH?

Zimmer Biomet Holdings, Inc.'s QOC of 3.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on ZBH?

CirclFi analyzes ZBH with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 13 of 13 are active for this stock. Read the full methodology →

Is ZBH a value trap in 2026?

Zimmer Biomet Holdings, Inc.'s Value Trap score is 12/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 13-model valuation engine, Zimmer Biomet Holdings, Inc. (ZBH) has a median fair value of $31.12 — 65.5% below the current price of $90.14 — as of 2026-07-15.” Source: circlfi.com/stock/ZBH/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 13 mathematical frameworks give you clarity on ZBH.

Unlock All 13 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access